New OptiForm® Solution Suite

September 11, 2017

Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.

Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.

The new service includes more comprehensive candidate screening tools, ADME considerations and in silico DMPK modeling, as well as additional bioavailability enhancing tools, to provide materials for cGLP toxicological studies, and on to first-in-human studies.

Catalent Pharma Solutions
14 Schoolhouse Rd, Somerset, NJ 08873 
tel. +1.888.SOLUTION (765.8846)
AAPS Booth #3016